- Home
- DERM vs IPSC Comparison
DERM vs IPSC Comparison
Compare DERM & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- IPSC
- Stock Information
- Founded
- DERM 2014
- IPSC 2019
- Country
- DERM United States
- IPSC United States
- Employees
- DERM N/A
- IPSC N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- DERM Health Care
- IPSC Health Care
- Exchange
- DERM Nasdaq
- IPSC Nasdaq
- Market Cap
- DERM 87.4M
- IPSC 77.3M
- IPO Year
- DERM 2021
- IPSC 2021
- Fundamental
- Price
- DERM $3.74
- IPSC $0.90
- Analyst Decision
- DERM Strong Buy
- IPSC Strong Buy
- Analyst Count
- DERM 3
- IPSC 4
- Target Price
- DERM $9.50
- IPSC $11.00
- AVG Volume (30 Days)
- DERM 61.7K
- IPSC 562.3K
- Earning Date
- DERM 11-12-2024
- IPSC 03-13-2025
- Dividend Yield
- DERM N/A
- IPSC N/A
- EPS Growth
- DERM N/A
- IPSC N/A
- EPS
- DERM N/A
- IPSC N/A
- Revenue
- DERM $57,771,000.00
- IPSC $2,684,000.00
- Revenue This Year
- DERM N/A
- IPSC $230.51
- Revenue Next Year
- DERM $36.49
- IPSC $31.87
- P/E Ratio
- DERM N/A
- IPSC N/A
- Revenue Growth
- DERM N/A
- IPSC 7.88
- 52 Week Low
- DERM $2.85
- IPSC $0.87
- 52 Week High
- DERM $6.89
- IPSC $5.51
- Technical
- Relative Strength Index (RSI)
- DERM 32.80
- IPSC 32.55
- Support Level
- DERM $3.54
- IPSC $0.87
- Resistance Level
- DERM $3.99
- IPSC $0.95
- Average True Range (ATR)
- DERM 0.35
- IPSC 0.09
- MACD
- DERM 0.00
- IPSC -0.00
- Stochastic Oscillator
- DERM 21.28
- IPSC 8.92
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.